Vascular Specialist Online

  • Home
  • Vascular Specialist Online

Vascular Specialist Online Vascular Specialist is the official newspaper of the SVS. News from the world of vascular surgery.

Imperative Care has announced Food and Drug Administration (FDA) 510(k) clearance of its Symphony thrombectomy system to...
03/09/2025

Imperative Care has announced Food and Drug Administration (FDA) 510(k) clearance of its Symphony thrombectomy system to treat pulmonary embolism (PE).

Imperative Care announces US FDA 510(k) clearance of its Symphony thrombectomy system to treat pulmonary embolism (PE).

The PAD Pulse Alliance—a coalition of leading medical societies that includes the Society for Vascular Surgery (SVS) ded...
03/09/2025

The PAD Pulse Alliance—a coalition of leading medical societies that includes the Society for Vascular Surgery (SVS) dedicated to improving vascular health—is urging patients, providers and policymakers to act through its Get a Pulse on PAD Campaign as national PAD Awareness Month kicks off.

The PAD Pulse Alliance is urging patients, providers and policymakers to act through its Get a Pulse on PAD Campaign as national PAD Awareness Month kicks off.

Cook Medical recently enrolled the final patient in the global clinical study of its Zenith Fenestrated+ endovascular gr...
01/09/2025

Cook Medical recently enrolled the final patient in the global clinical study of its Zenith Fenestrated+ endovascular graft (ZFEN+), signifying completion of patient recruitment in the pivotal study.

Cook Medical has enrolled the final patient in the global clinical study of its Zenith Fenestrated+ endovascular graft (ZFEN+), signifying completion of patient recruitment in the pivotal study. The investigational ZFEN+ clinical study is being conducted under an Investigational Device Exemption (...

News from Europe: Drug-coated balloons and stents were not associated with reduced risk of amputation or improved qualit...
01/09/2025

News from Europe: Drug-coated balloons and stents were not associated with reduced risk of amputation or improved quality of life compared with uncoated devices in the SWEDEPAD 1 and 2 trials.

Drug-coated stents and balloons were not associated with reduced risk of amputation or improved quality of life compared with uncoated devices in the SWEDEPAD 1 and 2 trials, according to late-breaking research presented today at ESC 2025.

Boston Scientific has recalled its Carotid Wallstent Monorail endoprosthesis owing to a “manufacturing defect” that has ...
28/08/2025

Boston Scientific has recalled its Carotid Wallstent Monorail endoprosthesis owing to a “manufacturing defect” that has led to devices having an inner lumen that is smaller than specifications, causing resistance when withdrawing the stent delivery system.

Boston Scientific has recalled its Carotid Wallstent Monorail endoprosthesis owing to a “manufacturing defect” that has led to devices having an inner lumen that is smaller than specifications, causing resistance when withdrawing the stent delivery system. A Food and Drug Administration (FDA) re...

The Society for Vascular Surgery's Journal of Vascular Surgery recently announced Audra Duncan of Western University as ...
28/08/2025

The Society for Vascular Surgery's Journal of Vascular Surgery recently announced Audra Duncan of Western University as its new editor-in-chief.

The Journal of Surgery (JVS) has appointed Audra Duncan, MD, of Western University in London, Ontario, Canada, as its new editor-in-chief.

A recent French study suggests smoking cessation in patients with peripheral arterial disease (PAD) is achievable with i...
28/08/2025

A recent French study suggests smoking cessation in patients with peripheral arterial disease (PAD) is achievable with intensive and appropriate management, with the prescription of a pharmacologic smoking cessation treatment and follow-up with smoking cessation services both identified as important elements that increase abstinence.

A recent French study suggests smoking cessation in patients with PAD is achievable with intensive and appropriate management, with the prescription of a pharmacologic smoking cessation treatment and follow-up with smoking cessation services both identified as important elements that increase abstin...

The latest Government Grand Rounds column in Vascular Specialist looks at developments in D.C. as Congress entered its s...
27/08/2025

The latest Government Grand Rounds column in Vascular Specialist looks at developments in D.C. as Congress entered its summer recess and what the Society for Vascular Surgery advocacy team is eyeing as September comes into view.

Congress entered summer recess after passing the One Big Beautiful Bill Act (OBBBA), which was signed into law by President Donald J. Trump on July 4. This law has various healthcare provisions that will affect Medicare and Medicaid, provider taxes and federal student loans.

In his August presidential update, Society for Vascular Surgery President Keith Calligaro summarized some of the critica...
27/08/2025

In his August presidential update, Society for Vascular Surgery President Keith Calligaro summarized some of the critical issues facing the Society. "There are more than 100 projects SVS committees, councils and task forces are working on, so I will focus on three or four issues each month," he informed members. Look out for his next update in the September issue of Vascular Specialist.

During the upcoming year, I plan to provide a monthly summary of critical issues the SVS is facing to keep you better informed. There are more than 100 projects SVS committees, councils and task forces are working on, so I will focus on three or four issues each month.

The speed with which artificial intelligence (AI) is beginning to envelope aspects of the human experience strikes many ...
27/08/2025

The speed with which artificial intelligence (AI) is beginning to envelope aspects of the human experience strikes many as jarring. Its entrance into the world of vascular surgery, too, has picked up a pace in recent years, with models and applications beginning to pop up in papers probing aspects of AI uses in care across the vasculature. But what is the extent of its abilities in vascular practice and where might AI lead the field in the future?

The speed with which artificial intelligence (AI) is beginning to envelope aspects of the human experience strikes many as jarring.

The Abbott  Esprit BTK everolimus-eluting resorbable scaffold system has received CE mark approval in Europe.
27/08/2025

The Abbott Esprit BTK everolimus-eluting resorbable scaffold system has received CE mark approval in Europe.

Abbott today announced it has received CE mark approval in Europe for the Esprit BTK everolimus-eluting resorbable scaffold system (Esprit BTK system), a technology designed for the treatment of below-the-knee (BTK) peripheral arterial disease (PAD). Abbott notes that the Esprit BTK system is the fi...

The Food and Drug Administration (FDA) has granted approval for Cook Medical to initiate an investigational device exemp...
20/08/2025

The Food and Drug Administration (FDA) has granted approval for Cook Medical to initiate an investigational device exemption (IDE) study on the Advance Evero 18 everolimus-coated percutaneous transluminal angioplasty (PTA) balloon catheter, the company reported today.

The FDA has granted approval for Cook Medical to initiate an investigational device exemption (IDE) study on the Advance Evero 18 everolimus-coated percutaneous transluminal angioplasty (PTA) balloon catheter.

Address


Alerts

Be the first to know and let us send you an email when Vascular Specialist Online posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

  • Want your business to be the top-listed Media Company?

Share